Developing Products and Maximizing Performance Through Group Synergies
First written in FY2018. 4 of 8 entries say "Restated". Latest entry: FY2026.
90 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The purpose is to accelerate business processes and decision-making from the development of materials through product sales by integrating 株式会社NRLファーマ’s development capabilities for functional materials centered on lactoferrin with 日本予防医薬株式会社’s e-commerce sales expertise, distribution channels and customer base.」
The materials development function of NRL Pharma and the e-commerce and customer base of 日本予防医薬 were integrated, giving concrete form to Group synergies through an organizational restructuring. - 2026-08-12AdvancedRevision of earnings forecasts
「The purpose is to accelerate business processes and decision-making from the development of materials through product sales by integrating 株式会社NRLファーマ’s development capabilities for functional materials centered on lactoferrin with 日本予防医薬株式会社’s e-commerce sales expertise, distribution channels and customer base.」
The integration of functional materials development capabilities with e-commerce sales and the customer base has been presented as a specific organizational reorganization intended to accelerate business processes and decision-making. - FY2023RestatedAnnual report
「Including its other businesses, the Company will work to expand each business, pursue synergies across the Group, maximize Group performance and promote efficient business operations.」
The Company cites services combining lactoferrin and healthcare support as examples, reconfirming its policy of developing products and services and operating efficiently through synergies across the Group. - FY2020AdvancedAnnual report
「For example, in January 2020, ㈱総合医科学研究所, which operates the healthcare support business, launched a specific health guidance service using lactoferrin, which has the effect of reducing visceral fat.」
A new service combining lactoferrin from the functional materials development business with the healthcare support business was launched in January 2020, turning Group synergies into a specific service. - FY2019-Q3RestatedAnnual report
「In June 2017, the Company made ㈱NRLファーマ, whose business consists of developing and selling functional materials centered on lactoferrin, a consolidated subsidiary. The Group plans to develop new products using lactoferrin in its cosmetics and health supplements businesses, while also actively pursuing the development of new materials by leveraging synergies with the company.」
The Company continues its policy of leveraging synergies with NRL Pharma to develop new cosmetics and health supplements, as well as new materials. - FY2019-Q2RestatedAnnual report
「In June 2017, the Company made ㈱NRLファーマ, whose business consists of developing and selling functional materials centered on lactoferrin, a consolidated subsidiary. The Group plans to develop new products using lactoferrin in its cosmetics and health supplements businesses, while also actively pursuing the development of new materials by leveraging synergies with the company.」
The Company continues its policy of leveraging synergies with NRL Pharma to develop new cosmetics and health supplements, as well as new materials. - FY2019-Q1RestatedAnnual report
「The Group plans to develop new products using lactoferrin in its cosmetics and health supplements businesses, while also actively pursuing the development of new materials by leveraging synergies with the company.」
The Company continues its policy of leveraging synergies with NRL Pharma to develop new cosmetics and health supplements, as well as new materials. - FY2018First statedAnnual report
「Including its other businesses, the Company will work to expand each business, pursue synergies across the Group, maximize Group performance and promote efficient business operations.」
The Company plans to combine the customer and information base of its healthcare support business with NRL Pharma's lactoferrin business, leading to product development, customer retention, information dissemination and efficient operations.